Bevacizumab for the management of low-grade serous ovarian cancer in first-line and recurrent disease

被引：0
|
作者：
Van Den Kieboom, Natalia [1 ]
Ottenbourgs, Tine [2 ]
Van Nieuwenhuysen, Els [3 ,4 ]
机构：
[1] Katholieke Univ Leuven, Leuven Canc Inst, Dept Gynaecol & Obstet, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven Canc Inst, Lab Gynaecol Oncol, Leuven, Belgium
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Luxembourg Gynaecol Oncol Grp BGOG, Leuven, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV338/#101
引用
收藏
页码：A258 / A259
页数：2
相关论文
共 50 条
  • [1] Encouraging responses with bevacizumab in recurrent low-grade serous ovarian cancer.
    Schmeler, K. M.
    Tao, X.
    Sun, C. C.
    Malpica, A.
    Deavers, M.
    Sood, A.
    Coleman, R. L.
    Bodurka, D. C.
    Kavanagh, J. J.
    Gershenson, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] First-Line Management of Advanced High-Grade Serous Ovarian Cancer
    Mahmood, Reem D.
    Morgan, Robert D.
    Edmondson, Richard J.
    Clamp, Andrew R.
    Jayson, Gordon C.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (06)
  • [3] First-Line Management of Advanced High-Grade Serous Ovarian Cancer
    Reem D. Mahmood
    Robert D. Morgan
    Richard J. Edmondson
    Andrew R. Clamp
    Gordon C. Jayson
    Current Oncology Reports, 2020, 22
  • [4] Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review
    Lazurko, Caitlin
    Linder, Revital
    Pulman, Kate
    Lennox, Genevieve
    Feigenberg, Tomer
    Fazelzad, Rouhi
    May, Taymaa
    Zigras, Tiffany
    CURRENT ONCOLOGY, 2023, 30 (09) : 8159 - 8171
  • [5] Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer
    Karacin, Cengiz
    Sunar, Veli
    Urakci, Zuhat
    Yilmaz, Ali
    Ayhan, Murat
    Ersoy, Mustafa
    Guven, Deniz Can
    Erturk, Ismail
    Durmus, Yasin
    Karacin, Pinar
    Boran, Nurettin
    Ustun, Yaprak Engin
    Meydan, Mutlu
    Dogan, Mutlu
    Oksuzoglu, Berna
    Ates, Ozturk
    Karaca, Mustafa
    Uncu, Dogan
    Ergun, Yakup
    Arik, Zafer
    FUTURE ONCOLOGY, 2024, 20 (04) : 207 - 214
  • [6] Low-Grade Serous Ovarian Cancer: a Unique Disease
    Schmeler, Kathleen M.
    Gershenson, David M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (06) : 519 - 523
  • [7] Low-grade serous ovarian cancer: a unique disease
    Kathleen M. Schmeler
    David M. Gershenson
    Current Oncology Reports, 2008, 10 : 519 - 523
  • [8] Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors
    Kulkarni, Anjali
    Cooke, Carly
    Fazelzad, Rouhi
    Fung-Kee-Fung, Michael
    May, Taymaa
    Zigras, Tiffany
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (01): : 11 - 16
  • [9] Targeting MAPK in recurrent, low-grade serous ovarian cancer Comment
    Blagden, Sarah P.
    LANCET, 2022, 399 (10324): : 499 - 501
  • [10] Controversies in the management of serous borderline tumors and low-grade serous ovarian cancer
    Ilenkovan, Narthana
    Ryan, Neil
    Roxburgh, Patricia
    Bell, Sarah
    Gourley, Charlie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2025, 35 (03)
12345